Sotera Health (SHC)
NASDAQ: SHC
· Real-Time Price · USD
11.45
-0.30 (-2.55%)
At close: Jun 13, 2025, 3:59 PM
11.43
-0.17%
After-hours: Jun 13, 2025, 04:44 PM EDT
Sotera Health Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Product Revenue | 158.62M | 143.69M | 138.86M | 125.98M |
| Product Revenue Growth | +10.39% | +3.48% | +10.23% | n/a |
| Service Revenue | 941.82M | 905.6M | 864.83M | 805.5M |
| Service Revenue Growth | +4.00% | +4.71% | +7.37% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Canada Revenue | 208.89M | 192.05M | 188.74M | 177.88M |
| Canada Revenue Growth | +8.77% | +1.75% | +6.11% | n/a |
| Europe Revenue | 196.01M | 187.54M | 166.03M | 161.81M |
| Europe Revenue Growth | +4.52% | +12.96% | +2.60% | n/a |
| Other Geographical Areas Revenue | 78.86M | 78.73M | 69.9M | 63.89M |
| Other Geographical Areas Revenue Growth | +0.17% | +12.63% | +9.42% | n/a |
| United States Revenue | 616.68M | 590.97M | 579.02M | 527.91M |
| United States Revenue Growth | +4.35% | +2.06% | +9.68% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 63.06M | 61.84M | 62.01M | 52.16M | 51.82M | 39.74M | 54.11M | 60.29M | 61.91M | 65.95M | 57.09M | 63.13M | 59.54M | 51.83M | 44.04M | 49.83M | 52.47M | 53.16M | 45.63M | 42.68M | 37.05M | 37.12M | 44.46M | 31.86M | 31.86M |
| Selling, General, and Administrative Revenue Growth | +1.98% | -0.28% | +18.87% | +0.67% | +30.37% | -26.55% | -10.24% | -2.62% | -6.12% | +15.52% | -9.57% | +6.03% | +14.89% | +17.69% | -11.62% | -5.03% | -1.30% | +16.49% | +6.91% | +15.20% | -0.18% | -16.50% | +39.56% | 0.00% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |